IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Sacheerome IPO is a book build IPO listing on NSE EMERGE exchange. The company is based in New Delhi and caters to Healthcare - Personal Care sector. GYR Capital Advisors Private is the merchant banker of Sacheerome IPO. It is a SME UPCOMING IPO which filed its Draft Red Herring Prospectus (DRHP) on 17th December 2024.
Sacheerome IPO posted revenues of Rs 101.56 crores and PAT of Rs 14.08 crores in FY25 on annualised basis.Financial results of Sacheerome IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Sacheerome IPO PAT Margin is 13.95%, ROCE (Return on Capital Employed) is 17.00% as per latest financial. The below table shows Sacheerome IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
The market Capitalisation of Sacheerome IPO is Rs [●] crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Sacheerome IPO prospectus highlights an Return on Equity (ROE) of 15%, Return on Assets (ROA) of 12%, and an EBITDA Margin of 18%, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Sacheerome IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Sacheerome IPO is ₹[●] Cr, based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Sacheerome IPO has a Price-to-Earnings (PE) ratio of [●], indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Sacheerome IPO reported revenue of ₹101.56 Cr in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Sacheerome IPO provide insights into sales growth, market demand, and business scalability.
Sacheerome recorded an EBITDA of ₹ 20.62 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Sacheerome Profit After Tax (PAT) is ₹14.08 Cr, reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 100.90 Cr.
EBITDA Margin:
20.44
%
Net Worth: ₹ 52.99 Cr.
Market Capitalisation:
[●]
P/E:
[●]
P/BV: [●]
EV/EBITDA: [●]
Sacheerome operates in Healthcare - Personal Care and . The Issue is listed on NSE EMERGE in Apr, 2025. Sacheerome IPO size was with Issue price of .
Merchant Banker(s) of Sacheerome IPO: GYR Capital Advisors Private Limited
Sacheerome IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Sacheerome IPO listed at a listing price of against the offer price of .
The current market price of Sacheerome is .
Why Us?
